Meditools International

The LumiraDx SARS-CoV-2 Ag Test is a microfluidic immunofluorescence assay for direct and qualitative detection of nucleocapsid proteins in nasal swab specimens from patients suspected of COVID-19. Used with the LumiraDx Instrument the Test delivers rapid results at the point of care.

TEST BENEFITS
The use of a LumiraDx SARS-CoV-2 Ag Test on the LumiraDx Instruments will enable the physician to verify infection quickly, begin proper treatment and to initiate isolation precautions helping prevent further spread of infection.
Easy to implement in point of care settings
Clinical performance
97.6% positive percent agreement
96.6% negative percent agreement
Analytical performance with a limit of detection of 32 TCID50/mL
RT-PCR comparable results within 12 days of onset of symptoms

Contact us to order now
[email protected]
08033808484
08038486589